PL2744798T3 - Pochodne tiazolu piperazyny użyteczne w leczeniu tauopatii, takich jak choroba alzheimera - Google Patents
Pochodne tiazolu piperazyny użyteczne w leczeniu tauopatii, takich jak choroba alzheimeraInfo
- Publication number
- PL2744798T3 PL2744798T3 PL12756402T PL12756402T PL2744798T3 PL 2744798 T3 PL2744798 T3 PL 2744798T3 PL 12756402 T PL12756402 T PL 12756402T PL 12756402 T PL12756402 T PL 12756402T PL 2744798 T3 PL2744798 T3 PL 2744798T3
- Authority
- PL
- Poland
- Prior art keywords
- tauopathies
- alzheimer
- disease
- treatment
- derivatives useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11177742 | 2011-08-17 | ||
| EP12756402.9A EP2744798B1 (en) | 2011-08-17 | 2012-08-17 | Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease |
| PCT/EP2012/066136 WO2013024168A1 (en) | 2011-08-17 | 2012-08-17 | Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2744798T3 true PL2744798T3 (pl) | 2016-08-31 |
Family
ID=46826450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12756402T PL2744798T3 (pl) | 2011-08-17 | 2012-08-17 | Pochodne tiazolu piperazyny użyteczne w leczeniu tauopatii, takich jak choroba alzheimera |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9187440B2 (pl) |
| EP (1) | EP2744798B1 (pl) |
| JP (1) | JP6051218B2 (pl) |
| CN (1) | CN103649062B (pl) |
| AU (1) | AU2012296804B2 (pl) |
| CA (1) | CA2841037C (pl) |
| ES (1) | ES2573299T3 (pl) |
| PL (1) | PL2744798T3 (pl) |
| WO (1) | WO2013024168A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012296804B2 (en) * | 2011-08-17 | 2017-04-20 | Remynd Nv | Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease |
| EP3119774A1 (en) * | 2014-03-17 | 2017-01-25 | reMynd NV | Oxadiazole compounds |
| WO2025104092A1 (en) * | 2023-11-13 | 2025-05-22 | Remynd N.V. | Modulators of septin 6 for use in the prevention and/or treatment of neurodegenerative disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004032567A1 (de) | 2004-07-05 | 2006-03-02 | Grünenthal GmbH | Substituierte 1-Propiolyl-piperazine |
| AU2005324024B2 (en) * | 2005-01-07 | 2011-02-17 | F. Hoffmann-La Roche Ag | [4-(Heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| EP1705474B1 (en) | 2005-03-21 | 2010-04-28 | F.Hoffmann-La Roche Ag | Method for determining lipophilicity |
| PE20070099A1 (es) * | 2005-06-30 | 2007-02-06 | Janssen Pharmaceutica Nv | N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso |
| GB0602335D0 (en) | 2006-02-07 | 2006-03-15 | Remynd Nv | Thiadiazole Derivatives For The Treatment Of Neurodegenerative Diseases |
| EP2121633A2 (en) * | 2007-02-12 | 2009-11-25 | Merck & Co., Inc. | Piperazine derivatives for treatment of ad and related conditions |
| ES2540956T3 (es) * | 2011-07-01 | 2015-07-15 | Remynd Nv | Derivados de 1,2,4-tiadiazol-5-ilpiperazina útiles en el tratamiento de enfermedades neurodegenerativas |
| AU2012296804B2 (en) | 2011-08-17 | 2017-04-20 | Remynd Nv | Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease |
-
2012
- 2012-08-17 AU AU2012296804A patent/AU2012296804B2/en not_active Ceased
- 2012-08-17 PL PL12756402T patent/PL2744798T3/pl unknown
- 2012-08-17 JP JP2014525462A patent/JP6051218B2/ja not_active Expired - Fee Related
- 2012-08-17 EP EP12756402.9A patent/EP2744798B1/en active Active
- 2012-08-17 ES ES12756402.9T patent/ES2573299T3/es active Active
- 2012-08-17 CN CN201280034129.3A patent/CN103649062B/zh not_active Expired - Fee Related
- 2012-08-17 WO PCT/EP2012/066136 patent/WO2013024168A1/en not_active Ceased
- 2012-08-17 US US14/238,905 patent/US9187440B2/en active Active
- 2012-08-17 CA CA2841037A patent/CA2841037C/en active Active
-
2015
- 2015-10-15 US US14/884,689 patent/US9808456B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20160101102A1 (en) | 2016-04-14 |
| US20140206699A1 (en) | 2014-07-24 |
| HK1192848A1 (zh) | 2014-09-05 |
| JP2014521737A (ja) | 2014-08-28 |
| CA2841037C (en) | 2020-03-31 |
| ES2573299T3 (es) | 2016-06-07 |
| CN103649062B (zh) | 2015-10-07 |
| US9808456B2 (en) | 2017-11-07 |
| CN103649062A (zh) | 2014-03-19 |
| JP6051218B2 (ja) | 2016-12-27 |
| EP2744798B1 (en) | 2016-03-30 |
| AU2012296804A1 (en) | 2014-01-30 |
| CA2841037A1 (en) | 2013-02-21 |
| WO2013024168A1 (en) | 2013-02-21 |
| AU2012296804B2 (en) | 2017-04-20 |
| US9187440B2 (en) | 2015-11-17 |
| EP2744798A1 (en) | 2014-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202012656WA (en) | Heterocyclic compounds useful in the treatment of disease | |
| IL259775B (en) | Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease | |
| EP2707369A4 (en) | COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE | |
| IL237369A0 (en) | Methods for treating Alzheimer's disease and pharmaceutical compositions thereof | |
| AP3807A (en) | Novel heterocyclic derivatives and their use in the treatment of neurological disorders | |
| HUE039731T2 (hu) | l,3-difenilprop-2-én-l-on-származékok alkalmazása májbetegségek kezelésére | |
| PL2985032T3 (pl) | Glyx do stosowania do leczenia choroby alzheimera, choroby parkinsona lub choroby huntingtona | |
| IL208350A0 (en) | Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease | |
| IL223819A0 (en) | 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia | |
| IL230957A0 (en) | Pharmacy methods and preparations for the treatment of an eye disease in a patient | |
| GB201105137D0 (en) | Therapeutic molecules for use in the suppression of Parkinson's disease | |
| SG11201403272YA (en) | Compositions and methods for treating alzheimer's disease | |
| PL2726470T3 (pl) | Pochodne 1,2,4-tiadiazol-5-ilo piperazyny przydatne w leczeniu chorób neurodegeneracyjnych | |
| TWI559929B (en) | Pharmaceutical composition for use in the treatment of a neurodegenerative disease | |
| IL230441A0 (en) | Diagnosis of Alzheimer's disease | |
| GB2515439B (en) | Vesicular formulations for use in the treatment of reduced mobility | |
| GB201511770D0 (en) | Novel pharmaceutical formulationsand their use in the treatment of periodontal disease | |
| CL2014003325A1 (es) | Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer | |
| ZA201402477B (en) | Compounds for use in the treatment of alzheimer's disease | |
| SG10201801200PA (en) | An h3 receptor antagonist for use in the treatment of alzheimer's disease | |
| IL239078A0 (en) | Protein for use in the treatment of eye diseases | |
| IL238071B (en) | Pharmaceutical composition of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof for the treatment of cardiovascular disease | |
| GB201101088D0 (en) | L-carnosine and cinnamon extract for the treatment of Alzheimer's Disease | |
| HK1195902A (en) | Compositions and methods for treating alzheimer's disease | |
| HK1230666A1 (en) | Determination of platelet-mirnas in alzheimer's disease |